Real-world challenges in eligibility for MMR vaccination two years after autologous and allogeneic HSCT. Punchhi G, Negus R, Saif H, Pritchard S, et al. Vaccine 2023 Aug 29:S0264-410X(23)00778-8. doi: 10.1016/j.vaccine.2023.

Read + Share

Amedeo Smart

Independent Medical Education

Punchhi G, Negus R, Saif H, Pritchard S, et al. Real-world challenges in eligibility for MMR vaccination two years after autologous and allogeneic HSCT. Vaccine 2023 Aug 29:S0264-410X(23)00778-8. doi: 10.1016/j.vaccine.2023.
PMID: 37652820